Curi Bio

Curi Bio

Curi Bio

Curi Bio develops humanrelevant platforms integrating human cells, systems, and data to accelerate the discovery of new medicines.
Type
B2b
Founded
2015
Raised
$6M
Follow us
Alexa global traffic share
Latest funding
$6,000,000
Venture capital (Series A) - 2021
Dynamk Capital
Team Size
1–10
Employees
GeekWire

Curi Bio raises $10M for stem-cell based drug discovery platforms

$6,000,000 Venture capital (Series A)
GeekWire

Seattle stem cell startup Curi Bio raises $6M